Deferred Tax Assets, Valuation Allowance of Tvardi Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tvardi Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Tvardi Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $200,656,000, a 4.1% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Tvardi Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $200,656,000 +$7,865,000 +4.1% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q4 2023 $192,791,000 +$31,977,000 +20% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $160,814,000 +$17,426,000 +12% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q4 2021 $143,388,000 +$22,722,000 +19% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q4 2020 $120,666,000 +$6,530,000 +5.7% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $114,136,000 +$24,321,000 +27% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $89,815,000 +$23,642,000 +36% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $66,173,000 -$618,000 -0.92% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $66,791,000 +$23,758,000 +55% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $43,033,000 +$10,317,000 +32% 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q4 2014 $32,716,000 +$7,156,000 +28% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q4 2013 $25,560,000 31 Dec 2013 10-K 27 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.